Your browser doesn't support javascript.
loading
Understanding the spectrum of cardiovascular risk in women - A primer for prevention.
Satish, Priyanka; Avenatti, Eleonora; Patel, Jaideep; Agarwala, Anandita.
Affiliation
  • Satish P; Center for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell Medical School, University of Texas, Austin, USA.
  • Avenatti E; Center for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell Medical School, University of Texas, Austin, USA.
  • Patel J; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Agarwala A; Center for Cardiovascular Disease Prevention, Baylor Scott and White Health Heart Hospital Baylor Plano, Plano, TX, USA. Electronic address: anandita.kulkarni@bswhealth.org.
Prog Cardiovasc Dis ; 84: 34-42, 2024.
Article in En | MEDLINE | ID: mdl-38710313
ABSTRACT
Cardiovascular disease (CVD) is the leading cause of death in women worldwide and the lifetime risk of CVD in women is similar to men. However, the pathophysiology of CVD varies between women and men necessitating a sex-specific understanding of cardiovascular (CV) risk. A belief that women have a lower CVD risk than men, and an underrepresentation in clinical research for many years has led to a paucity of evidence in the prevention and management of CVD in women. Many recent efforts have tried to bridge the gap. As a result, we now know that traditional risk factors impact CVD risk differently in women when compared with men. There are also numerous sex-specific and pregnancy related risk factors that modify the risk and can predict the future development of CVD in women. This is important as risk calculators, in general, tend to misclassify risk in young women with nontraditional CVD risk factors. To address this, guidelines have introduced the concept of risk enhancers that can suggest a higher risk. The use of coronary artery calcium score can further accurately delineate risk in these women, leading to an appropriate matching of therapy to underlying risk. This review discusses implementation strategies that are essential to mitigate disparities in CVD outcomes and optimizing CVD risk in women.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Women's Health / Heart Disease Risk Factors Limits: Female / Humans / Pregnancy Language: En Journal: Prog Cardiovasc Dis Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Women's Health / Heart Disease Risk Factors Limits: Female / Humans / Pregnancy Language: En Journal: Prog Cardiovasc Dis Year: 2024 Document type: Article Affiliation country:
...